Estimates Revisions DSM-Firmenich Börse Stuttgart
Stocks
ZX61
US23346J1034
Consumer Goods Conglomerates
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.850 EUR | +7.93% |
|
+14.19% | +26.43% |
| 07-31 | European chemical firms post solid Q2 results but stay cautious on outlook | RE |
| 07-30 | DSM-Firmenich AG, H1 2026 Earnings Call, Jul 30, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DSFIR Stock
- ZX61 Stock
- Consensus DSM-Firmenich
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
